Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Terminated 3Withdrawn 1Unknown 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Spinal Stenosis 1Pancreatic Neoplasms 1Pain, Postoperative 1Head and Neck Neoplasms 1Chronic Pain 1Breast Neoplasms 1Anxiety Disorders 1

Interventions

Cognitive Behavioral Therapy 4Psilocybin 3Therapeutics 2Oxygen 2Music Therapy 2Methods 2Waiting Lists 1Transurethral Resection of Prostate 1Touch 1Thyroidectomy 1TEMPO 1Surveys and Questionnaires 1Standard of Care 1Sertraline 1Selective Serotonin Reuptake Inhibitors 1Respiration 1Referral and Consultation 1Psychotherapy 1Pharmaceutical Preparations 1Paramedics 1Palliative Care 1Niacin 1Midazolam 1Methylphenidate 1Melatonin 1Ketamine 1Injections 1Hypnosis 1Glutamyl Aminopeptidase 1Fluoxetine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Anxiety Disorders × Ketamine × Clear all
NCT05086250 2026-05-08

Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer

Cedars-Sinai Medical Center

Phase EARLY_PHASE1 Recruiting
20 enrolled
Gastrointestinal

Anxiety Disorders, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡